Light Treatment of Vaginal Infections in Reproductive Age Women
NCT06985433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2026-02-17
Summary
Antimicrobials have helped in managing vaginal dysbiotic conditions such as bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). However, their increasing inefficiency and rise in antimicrobial resistance (AMR) is a challenge and threat to public health. Therefore, this study will investigate the safety and efficacy of light as an antimicrobial to treat vulvovaginal infections.
Conditions
- Bacterial Vaginosis
- Vulvovaginal Candidiases
Interventions
- DEVICE
-
Vaginal Light Therapy - Once
Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in single treatment session.
- DEVICE
-
Vaginal Light Therapy - Twice
Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in two treatment sessions.
- DEVICE
-
Vaginal Light Therapy - Twice
Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in two treatment sessions.
- DEVICE
-
Vaginal light therapy - Once
Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in single treatment session.
Sponsors & Collaborators
-
Odense University Hospital
collaborator OTHER -
UVISA Health ApS
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-05
- Primary Completion
- 2025-12-29
- Completion
- 2026-02-02
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
NCT06450990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Transplantation of Vaginal Mikrobiome
NCT04855006 ·Status: COMPLETED ·Phase: NA
-
EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS
NCT05649735 ·Status: COMPLETED ·Phase: NA
-
Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis
NCT02185456 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Vaginal Ecosystem and Network in the United States Study
NCT06472765 ·Status: ENROLLING_BY_INVITATION
-
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
NCT07109869 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment of Bacterial Vaginosis With Oral Tinidazole
NCT00229216 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis
NCT03762083 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463
NCT01812889 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis
NCT02418845 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
NCT02147899 ·Status: COMPLETED ·Phase: PHASE2
-
Suppression Of Bacterial Vaginosis (BV) [SUBVert]
NCT03930745 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
NCT02314429 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis
NCT02687789 ·Status: COMPLETED ·Phase: NA
-
Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
NCT07199998 ·Status: RECRUITING
-
A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group
NCT06123299 ·Status: COMPLETED ·Phase: NA
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308033 ·Status: COMPLETED ·Phase: PHASE3
-
First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories
NCT05340790 ·Status: RECRUITING ·Phase: PHASE1
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
NCT05753813 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
TOL-463 Phase 2 Study for Vaginitis
NCT02866227 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
NCT07234786 ·Status: RECRUITING ·Phase: NA
-
Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis
NCT04640922 ·Status: COMPLETED ·Phase: NA
-
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
NCT00706368 ·Status: UNKNOWN ·Phase: NA
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308046 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
NCT02432404 ·Status: COMPLETED ·Phase: PHASE4